Page last updated: 2024-09-05

sk&f 107260 and echistatin

sk&f 107260 has been researched along with echistatin in 1 studies

Compound Research Comparison

Studies (sk&f 107260)	Trials (sk&f 107260)	Recent Studies (post-2010) (sk&f 107260)	Studies (echistatin)	Trials (echistatin)	Recent Studies (post-2010) (echistatin)
11	0	0	184	0	22

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, FE; Bennett, D; Bondinell, W; Chen, W; Heys, JR; Hwang, SM; Johanson, K; Ku, TW; Landvatter, SW; Nichols, AJ; Powers, DA; Samanen, J; Stadel, JM; Wong, A	1

Other Studies

1 other study(ies) available for sk&f 107260 and echistatin

Article	Year
Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:1 Topics: Binding, Competitive; Blood Platelets; Cations, Divalent; Dose-Response Relationship, Drug; Fibrinogen; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex	1998

Article

Year

Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.

The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:1

Topics: Binding, Competitive; Blood Platelets; Cations, Divalent; Dose-Response Relationship, Drug; Fibrinogen; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

1998